Valuation for National Health Investors (id:9418 NHI)
Financial Strength
| Name | Current | Vs Industry | Vs History |
|---|---|---|---|
| Trailing P/E | 24.00 |
|
|
| Forward P/E | 22.25 |
|
|
| Price to sales | 9.62 |
|
|
| Price to book | 2.07 |
|
|
| Enterprise to revenue | 13.99 |
|
|
| Enterprise to ebitda | 18.01 |
|
|
| PEG ratio | 22.25 |
|
|
| Price to operating cash flow | 15.60 |
|
|